[HTML][HTML] A phase 2 randomized, double-blind, placebo-controlled trial demonstrating reversal of rivaroxaban-induced anticoagulation in healthy subjects by andexanet …
C Mark, M Vandana, K Michael, L Genmin, PB Conley… - Blood, 2013 - Elsevier
Abstract Background Direct factor Xa inhibitors have demonstrated compelling anticoagulant
efficacy and/or safety profiles across multiple diverse patient populations. A specific antidote …
efficacy and/or safety profiles across multiple diverse patient populations. A specific antidote …
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet …
C Mark, M Vandana, K Michael, L Genmin, PB Conley… - 2013 - ashpublications.org
Abstract Background Direct factor Xa inhibitors have demonstrated compelling anticoagulant
efficacy and/or safety profiles across multiple diverse patient populations. A specific antidote …
efficacy and/or safety profiles across multiple diverse patient populations. A specific antidote …